logo
logo
Clarivate Plc

Clarivate Plc

NYSE•CLVT
CEO: Mr. Jonathan M. Collins
セクター: Technology
業種: Information Technology Services
上場日: 2018-10-29
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
連絡先情報
70 St. Mary Axe, London, EC3A 8BE, United Kingdom
44-20-7433-4000
www.clarivate.com
時価総額
$1.18B
PER (TTM)
-3.0
25.3
配当利回り
--
52週高値
$5.16
52週安値
$1.74
52週レンジ
1%
順位65Top 96.0%
1.6
F-Score
改良版 Piotroski 分析
8年ファンダメンタル
弱い • 1.6 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2018-2025

財務ダッシュボード

Q3 2025 データ

売上高

$623.10M+0.14%
直近4四半期の推移

EPS

-$0.04-53.67%
直近4四半期の推移

フリーCF

$115.50M-8.55%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Operating Income Swing Positive Operating income $30.1M YTD 2025 versus $(213.3)M loss in 2024; driven by lower impairments. (17 words)
Net Loss Significantly Narrows Net loss attributable to ordinary shares $204.2M YTD 2025, substantially improved from $476.2M loss prior year. (18 words)
Organic ACV Growth Steady Organic Annualized Contract Value grew 1.6% versus September 2024, reflecting pricing increases across subscription base. (17 words)
Impairment Charges Eliminated Goodwill and intangible asset impairments totaled $0M YTD 2025, compared to $316.6M charge recognized in 2024. (17 words)

リスク要因

Total Revenues Declining Total revenues down 2.9% YTD to $1,838.2M, impacted by divestitures and product group wind-downs across segments. (18 words)
Restructuring Costs Increase Restructuring and other impairments rose to $45.9M YTD 2025, primarily due to ongoing Value Creation Plan execution. (17 words)
Total ACV Decreases Total ACV declined 3.4% to $1,542.7M due to ScholarOne divestiture and wind-down of certain product groups. (17 words)
Legal Proceedings Exposure Engaged in ongoing securities class action litigation; ultimate resolution and financial impact remain uncertain at this stage. (18 words)

見通し

Liquidity Position Strong Cash on hand $318.7M; $768.5M available borrowing capacity under revolving credit facility as of September 30, 2025. (19 words)
Share Repurchase Program Active $350.5M availability remains under the $500.0M repurchase authorization valid through December 31, 2026. (17 words)
Value Creation Plan Progress Value Creation Plan restructuring expected to be substantially completed by the end of 2025, focusing on cost optimization. (18 words)
Capital Needs Forecasted Forecasts indicate operating cash flow and capacity adequate for debt service, capital expenditures, and business plans for 12 months. (20 words)

同業比較

売上高 (TTM)

DXC Technology CompanyDXC
$12.68B
-1.9%
Concentrix CorporationCNXC
$9.83B
+2.2%
ASGN IncorporatedASGN
$3.98B
-2.9%

粗利益率 (最新四半期)

Clarivate PlcCLVT
65.0%
-1.3pp
Innodata Inc.INOD
41.4%
-0.4pp
Pagaya Technologies Ltd.PGY
40.8%
+0.7pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
VNET$3.70B-45.0-9.3%61.5%
DXC$2.33B5.613.4%36.3%
GLOB$2.13B21.64.8%14.2%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-2.0%
横ばい
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年2月18日
|
EPS:$0.16
|
売上高:-
財務レポート
財務データ
ニュース
全年度
  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年10月29日|
    売上高: $623.10M+0.1%
    |
    EPS: $-0.04-53.7%
    予想を下回る
  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年7月30日|
    売上高: $621.40M-4.4%
    |
    EPS: $-0.11-76.1%
    予想を下回る
  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年4月29日|
    売上高: $593.70M-4.4%
    |
    EPS: $-0.15+36.4%
    予想を下回る
  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年2月19日|
    売上高: $2.56B-2.7%
    |
    EPS: $-0.96+34.7%
    予想を下回る
  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月6日|
    売上高: $622.20M-3.9%
    |
    EPS: $-0.09+831.6%
    予想を下回る
  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月6日|
    売上高: $650.30M-2.8%
    |
    EPS: $-0.46+155.6%
    予想を下回る
  • Form 10-Q - Q1 2024

    会計期末: 2024年3月31日|提出日: 2024年5月8日|
    売上高: $621.20M-1.3%
    |
    EPS: $-0.11-400.5%
    予想を下回る
  • Form 10-K - FY 2023

    会計期末: 2023年12月31日|提出日: 2024年2月27日|
    売上高: $2.63B-1.2%
    |
    EPS: $-1.47+76.5%
    予想を下回る